welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 323 blog entries.

Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials

TO NOTE: This MSN is the one of two covering supply issues with insulin vials. MSN/2024/057 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSN (MSN/2024/072) covers Humalog® (insulin lispro). CAUTION: These products have similar sounding names and appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific [...]

The post Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials appeared first on Community Pharmacy England.

By |June 18th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials

MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan)

Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Drug alert number: EL (24)A/22 Date issued: 17 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) Company name: Viatris UK Healthcare [...]

The post MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan) appeared first on Community Pharmacy England.

By |June 17th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Oxcarbazepine Mylan 150 mg, 300mg, 600mg Film-Coated Tablets (Mylan)

Medicine Supply Notification: Erythromycin 250mg gastro-resistant tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Erythromycin 250mg gastro-resistant tablets MSN/2024/071 Tier 2 – medium impact Date of issue: 12th June 2024 Erythromycin 250mg tablets are currently out of stock until w/c 24th of June 2024. Erythromycin 500mg tablets remain available but are unable to support an [...]

The post Medicine Supply Notification: Erythromycin 250mg gastro-resistant tablets appeared first on Community Pharmacy England.

By |June 12th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Erythromycin 250mg gastro-resistant tablets

MHRA Class 4 medicines defect information: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited)

Class 4 Medicines Defect Information: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited) Drug alert number: EL (24)A/21 Date issued: 10 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited) Company name: Dawa Limited Product name: Paracetamol [...]

The post MHRA Class 4 medicines defect information: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited) appeared first on Community Pharmacy England.

By |June 10th, 2024|Lexpos News|Comments Off on MHRA Class 4 medicines defect information: Paracetamol 500mg, 1000mg film coated tablets (Dawa Limited)

Medicine Supply Notification: Quetiapine 150mg, 200mg, 300mg tablets – Updated

Update: (17/07/24) changes shown in bold below Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 150mg, 200mg, 300mg tablets MSN/2024/070 Tier 2 – medium impact Date of issue: 6th June 2024 There are limited supplies of quetiapine 150mg, 200mg and 300mg tablets until late August 2024. Subject to [...]

The post Medicine Supply Notification: Quetiapine 150mg, 200mg, 300mg tablets – Updated appeared first on Community Pharmacy England.

By |June 6th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Quetiapine 150mg, 200mg, 300mg tablets – Updated